Moderator: Rebecca A. Cerrato, MD 
Faculty: Samuel E. Ford, MD; Steven K. Neufeld, MD; Patrick J. Maloney, MD; Elizabeth Cody, MD

This webinar will review treatments for hallux valgus deformities including minimally invasive techniques and managing complications after MIS surgery, indications for open surgery, and review management of hallux valgus in the setting of other foot deformities.

Agenda

• Minimally Invasive Hallux Valgus Correction Osteotomy Planning and Techniques - Samuel E. Ford, MD
• Managing Complications After Mis Hallux Valgus Correction - Steven K. Neufeld, MD
• In An MIS World, When to Do Open Bunion Correction - Patrick J. Maloney, MD
• Managing Hallux Valgus in The Setting Of Other Associated Deformities – Elizabeth Cody, MD

At the conclusion of this webinar, you will be able to:

• Understand indications and techniques for minimally invasive hallux valgus correction 
• Discuss complications in MIS correction and how to manage them 
• Review considerations of when to perform open hallux valgus correction 
• Review management strategies of hallux valgus in the setting of concomitant foot deformities 

Course Objectives

At the conclusion of this webinar, you will be able to:

• Identify unique issues and different treatment options for patients with hammertoes that have MTP arthritis.
• Identify unique issues and different treatment options for patients with hammertoes that have MTP instability.
• Understand how complex medical issues (i.e. DM, RA, etc.) effect surgical options for complex hammertoes.
• Understand how patient expectations can influence outcomes of hammertoe corrections.

Commercial Support
2024 webinars are provided free to AOFAS members and orthopaedic residents/fellows with funding from the Orthopaedic Foot & Ankle Foundation, supported by grants from Stryker.

Accreditation

The American Orthopaedic Foot & Ankle Society (AOFAS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

Credit Designation Statement

The AOFAS designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

A need for this educational activity has been determined based on previous course evaluations and the AOFAS educational curriculum. The content of this course was based on current issues and topics provided by AOFAS membership and leadership. For more information on the AOFAS CME mission, visit aofas.org/education.

AOFAS requires all instructors, planners, and other individuals in a position to control or influence the content of an educational activity to disclose all relevant financial relationships or affiliations during the past 12 months with any commercial interest (any entity producing, marketing, re-selling, or distributing healthcare goods and services consumed by, or used on patients). All identified conflicts of interest must be resolved and the education content vetted by AOFAS for fair balance, scientific objectivity, and appropriateness. AOFAS also requires faculty to disclose when off-label/unapproved uses of a product are discussed in a CME activity. AOFAS attests that the persons responsible for the development of this educational activity did so independently and were not influenced by commercial supporters. All financial disclosures will be provided to meeting attendees in the final program materials.

The material presented in this continuing medical education activity has been made available by the American Orthopaedic Foot & Ankle Society (AOFAS) for educational purposes only. This material is not intended to represent the only, nor necessarily the best, methods or procedures appropriate for the medical situation discussed, but rather is intended to present an approach, view, statement, or opinion of the authors or presenters, which may be helpful or of interest to other practitioners. Methods, techniques, and procedures demonstrated and views and opinions expressed by speakers, presenters, and faculty are their own, and do not necessarily represent those of AOFAS, nor does presentation on the program represent or constitute endorsement or promotion by AOFAS. AOFAS expressly disclaims any warranties or guarantees, expressed or implied, and shall not be liable for damages of any kind in connection with the material, methods, information, techniques, opinions, or procedures expressed, presented, or demonstrated.

FDA Statement
Some drugs or medical devices demonstrated at this meeting have not been cleared by the FDA or have been cleared by the FDA for specific purposes only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or medical devices he or she wishes to use in clinical practice. AOFAS policy provides that “off label” uses of a drug or medical device may be described in its CME activities so long as the “off label” use of the drug or medical device is also specifically disclosed (i.e., it must be disclosed that the FDA has not cleared the drug or device for the described purpose). Any drug or medical device is being used “off label” if the described use is not set forth on the products approval label.

Faculty/Planner Disclosure Declaration
As an Accreditation Council for Continuing Medical Education (ACCME) provider, AOFAS has the obligation to ensure the delivery of education that is balanced and free of commercial bias. To achieve this, it is the policy of the AOFAS that all CME-related board members, committee members (“planners”), faculty, and appropriate staff disclose in writing to the learners’ all financial relationships that you have had in the past 24 months with ineligible companies. An “ineligible company” are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

In addition to faculty members, commentators from the floor are charged with verbally disclosing any interests immediately prior to speaking. All disclosures are provided in this final program distributed at the meeting to all program participants.

In accordance with AOFAS policy:
Faculty participation in this educational activity will be predicated upon timely submission and review of AOFAS disclosure. An individual who refuses to disclose all financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for, the development, management, presentation, or evaluation of the CME activity. Non-compliance will result in a faculty member being stricken from the program.

An indication of the participant’s disclosure appears after his or her name as well as the ineligible company that provided the support. AOFAS does not view the existence of these disclosed interests or commitments as necessarily implying bias or decreasing the value of the author’s participation in this activity. In addition to ensuring that presentations be free of bias, faculty members are required to ensure that all material presented and discussed will be based on best- available evidence.

Rebecca A. Cerrato, MD
Acumed: Speakers' Bureau 
AOFAS: Board member/Committee Member 
CurveBeam: Speakers' Bureau (Terminated)
MIFAS: Board member/Committee Member 
Stryker/Wright Medical: Paid Consultant, Royalties, Speakers' Bureau 

Elizabeth Cody, MD
DT MedTech: Paid Consultant 
Stryker: Paid Consultant 

Samuel E. Ford, MD
Acera Surgical: Paid Consultant 
Acumed LLC: Paid Consultant 
Bone Support: Paid Consultant 
Celling Biosciences: Paid Consultant 
Ossio: Paid Consultant 
Restor3d: Paid Consultant, Royalties, Stock-privately held company 
Stryker: Paid Consultant, Royalties 

Patrick J. Maloney, MD
Arthrex: Paid Consultant 
Paragon28: Grant/Research Support, Paid Consultant 

Steven K. Neufeld, MD
ConMed: Royalties, consultant & research support
Stryker: Royalties, consultant
Artelon: Royalties, consulting & research support
Ossio: Consulting
Merete: Royalties
JBJS: Reviewer
FAI: Reviewer
JAAOS: Reviewer
American Family Physician: Reviewer

Amgad M. Haleem, MD, PhD (Planner)
Stryker: Paid Consultant; Speakers’ Bureau
Vilex Medical: Paid Consultant; Speakers’ Bureau

Ashlee P. MacDonald, MD (Planner)
Nothing to Disclose

All of the relevant financial relationships listed for these individuals have been mitigated.